Surmodics Inc expected to post a loss of 66 cents a share - Earnings Preview

SurModics

03/02/2023 23:43

* Surmodics Inc  SRDX.OQ   SRDX.O  is expected to show a
rise in
quarterly revenue when it reports  results on February 6. 
    * The Eden Prairie Minnesota-based  company is expected to
report 
a 4.2% increase in revenue to $23.968 million from $23 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. The company's guidance on November 9 2022,
for the period ended December 31, was for revenue between $20.93
million and $21.39 million.
    * ​Refinitiv's mean analyst estimate for Surmodics Inc is
for a
loss of 66 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Surmodics
Inc is
$53.5​, above​ its last closing price of $29.95. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.45       -0.45      -0.26     Beat    42.4
 Jun. 30 2022  -0.38       -0.38      -0.34     Beat    11.3
 Mar. 31 2022  -0.35       -0.34      -0.22     Beat    35.3​
 Dec. 31 2021  -0.31       -0.31      -0.13     Beat    58.5
 ​​Sep.        -0.25       -0.25      -0.10     Beat    60
 30 2021                                                
 Jun. 30 2021  -0.15       -0.17      -0.17     Met     -2​
 Mar. 31 2021  0.66        0.63       0.62      Missed  -2.1
 Dec. 31 2020  -0.08       -0.09      0.02      Beat    122.2
 This summary was machine generated February 3 at 23:43 GMT.  All
figures in US dollars  unless otherwise stated